2024 CERSI Summit - Panel 3: Accelerating CMC Commercialization
Moderators:
Aine Hanly, PhD – Executive Vice President and Chief Technology Officer at Vir Biotechnology
Peter Marks, MD, PhD – Director, Center for Biologics Evaluation and Research (CBER) at FDA
Panelists:
Chetan Goudar, PhD – Vice President, Process Development at Amgen
Lynne Krummen, PhD – Executive Vice President, Regulatory/Program Leadership at Vir Biotechnology
Alison Moore, PhD -CMC Executive
Matthew Porteus, MD, PhD – Professor of Pediatrics – Stem Cell Transplantation at Stanford University
Noemi Romero – Senior Vice President, Global Supply Chain & Manufacturing Strategy at Eli Lilly
https://cersisummit.com/